Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn’s Disease Treated Until 33 Weeks of Gestation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn’s Disease Treated Until 33 Weeks of Gestation
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 12, Issue 3, Pages 376-378
Publisher
Oxford University Press (OUP)
Online
2017-10-13
DOI
10.1093/ecco-jcc/jjx141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proper Use of Inflammatory Bowel Disease Drugs during Pregnancy
- (2016) S.L. Kanis et al. DIGESTIVE DISEASES
- The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
- (2016) Geoffrey C. Nguyen et al. GASTROENTEROLOGY
- Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature
- (2016) X. Cortes et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis
- (2015) E. Galli-Novak et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- 865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy
- (2015) Uma Mahadevan et al. GASTROENTEROLOGY
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
- (2012) Uma Mahadevan et al. Clinical Gastroenterology and Hepatology
- Discovery and mechanism of ustekinumab
- (2012) Jacqueline M. Benson et al. mAbs
- High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy
- (2011) Z. Zelinkova et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31
- (2011) Casper Steenholdt et al. Journal of Crohns & Colitis
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics
- (2010) Uma Mahadevan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation
- (2010) Pauline L. Martin et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Reproductive wish represents an important factor influencing therapeutic strategy in inflammatory bowel diseases
- (2009) Zuzana Zelinkova et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy
- (2008) Sunanda V Kane et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started